Abstract. The monoterpene perillyl alcohol (POH) is a naturally occurring compound derived from citrus fruits, mint and herbs. It exhibited chemotherapeutic potential against various malignant tumors in preclinical models and is currently being tested in clinical trials in patients with refractory advanced cancers. POH inhibits cellular proliferation at the G1 phase of the cell cycle in vitro. However, the molecular mechanisms responsible for this effect have not been sufficiently elucidated. Here we showed that 1.0 mM POH upregulates p15
Introduction
Regulation of the cell cycle is important in cellular proliferation, and therefore the loss of cell cycle control is involved in carcinogenesis (1) . Cyclins and cyclin-dependent kinases (CDKs), in association with each other, play pivotal roles in promoting the transition of cells from the G1 phase to the S phase of the cell cycle by phosphorylating the tumor-suppressor retinoblastoma (RB) protein (2, 3) . Cyclin-CDK complex activation is negatively regulated by CDK inhibitors (CKIs). The first family of CKIs, referred to as the CIP/KIP family, consists of p21 WAF1/Cip1 , p27
Kip1 and p57 Kip2 . Each member inhibits a broader spectrum of cyclin/CDK complexes including cyclin E/A-CDK2 and cyclin D-CDK4/6 (4, 5) . The second family of CKIs is called the INK4 family, which comprises p15 INK4b , p16 INK4a , p18 INK4c and p19 INK4d . These molecules are specific inhibitors of cyclin D-CDK4/6 complexes (5, 6) . Many studies have shown that RB is directly, or indirectly, inactivated in most human cancers. Abnormalities leading to malignancies frequently relate to loss or dysfunction of tumor-suppressor molecules including members of these two CKI families, which activate the RB pathway (5, 7) .
Perillyl alcohol (POH) is a naturally occurring monoterpene found in the essential oils of cherry, lemongrass, gingergrass, cranberry, perilla, mint, lavender, sage, wild bergamot, caraway and celery seeds (8, 9) . It has been shown that POH exerts antitumor activity against malignant tumor cells in vitro and in vivo. POH inhibits the growth of various types of malignant tumor cells in vitro through blockade of proliferation, angiogenesis and migration, and induction of differentiation and apoptosis (10) (11) (12) (13) (14) . Regarding the antiproliferative activity of POH, this monoterpene is reported to cause cell cycle arrest at the G1 phase through downregulation of cyclin D1 and upregulation of p21 WAF1/Cip1 in murine mammary transformed cells or through upregulation of both p21 WAF1/Cip1 and p27
Kip1 in human pancreatic adenocarcinoma cells (15, 16) . Moreover, POH significantly inhibits the growth of mammary and liver tumors in rodent models (12, 17) . Based on these preclinical data, clinical studies using POH have commenced in patients with advanced malignancies. However, two phase II studies in patients with refractory metastatic breast cancer and metastatic androgen-independent prostate cancer reported that no objective responses were observed (18, 19) . On the other hand, a recent clinical study showed that intranasal administration of POH increased the overall survival of patients with recurrent glioblastoma (20) .
In this study, we demonstrated that POH caused G1 arrest in malignant tumor cells through p15
INK4b and p21
induction leading to the dephosphorylation of the RB protein.
We suggest that not only p21 WAF1/Cip1 but also p15 INK4b could be important molecular targets that mediate the antitumor effects of POH.
Materials and methods
Cell culture and reagents. Human immortalized keratinocyte HaCaT cells were a kind gift from Dr N.E. Fusenig, German Cancer Research Center, Heidelberg, Germany. Human colon cancer cell lines HT-29 and SW620 were obtained as cell lines of NCI-60 from the NCI Developmental Therapeutics Program (NCI DTP). These cells were maintained in DMEM supplemented with 10% fetal bovine serum, 4 mM L-glutamine, 100 U/ml penicillin and 100 µg/ml streptomycin. Cell cultures were incubated at 37˚C in a humidified atmosphere with 5% CO 2 . POH was purchased from Wako (320-52902; Osaka, Japan), dissolved in dimethyl sulfoxide (DMSO) and diluted to the final concentrations in each volume of culture medium used.
Growth inhibition assay. Cells were plated at 5x10 4 cells in 12-well plates. One day after inoculation of cells, various concentrations of POH were added to the culture medium. From the first to the second day after plating, the numbers of viable cells were counted using a trypan blue dye exclusion test.
Cell cycle analysis. For flow cytometry, 5x10
4 cells were plated in 12-well plates. One day later, unsynchronized cells were exposed to 1.0 mM POH for 24 h. The cells were then treated with Triton X-100 and RNase A, and their nuclei were stained with propidium iodide before DNA content was measured using a BD FACS Calibur flow cytometer (BD Biosciences, Franklin Lakes, NJ). At least 10,000 cells were counted and the ModFit LD V2.0 software package (BD Biosciences) was used to analyze the data.
Protein isolation and western blot analysis. Cells were lysed in SDS buffer [50 mM Tris-HCl (pH 7.5), 1% SDS]. The protein extract was then boiled for 5 min and loaded onto a 12% (for p15
INK4b and p21 WAF1/Cip1 detection), a 10% (for α-tubulin detection) or a 5% (for RB detection) polyacrylamide gel, subjected to electrophoresis and transferred to a nitrocellulose membrane. The following primary antibodies were used: anti-p15
INK4b (sc-612; Santa Cruz Biotechnology, Inc., Santa Cruz, CA) anti-p21 WAF1/Cip1 (sc-397; Santa Cruz Biotechnology, Inc.), anti-p27
Kip1 (sc-528; Santa Cruz Biotechnology, Inc.), anti-pRB (554136; BD Pharmingen) and anti-α-tubulin (CP06; Calbiochem, San Diego, CA). The signal was then developed with Chemi-Lumi One (Nacalai Tesque, Kyoto, Japan) or Immobilon Western (EMD Millipore, MA).
RNA isolation and real-time reverse transcription (RT)-PCR.
Real-time RT-PCR analysis was performed as previously described (21) . The GeneAmp5700 (Applied Biosystems, CA) was used to quantify the expression level of p15 INK4b and p21 WAF1/Cip1 mRNAs and normalized to β2MG mRNA. Real-time RT-PCR primer probes for p15
INK4b (Hs00394703), p21 WAF1/Cip1 (Hs00355782) and β2MG (Hs99999907) were purchased from Applied Biosystems.
Transfection and luciferase assay. The p15
INK4b -luciferase fusion plasmid was described previously (22) . HaCaT cells were seeded at 1.6x10 5 cells/well in 6-well plates. One day later, cells were transfected with the plasmid or pGVB2 (a vacant control; 2.5 µg) using Lipofectamine LTX and Plus reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. After 24 h, transfected cells were treated with POH at various concentrations for 12 h and then harvested. Luciferase assays were then performed using luciferase assay reagents (Promega, Madison, WI) and a luminometer.
Small interfering RNA (siRNA). The p15
INK4b (CDKN2B HSS141533) and the negative control (Negative Universal Control High #3) siRNAs were purchased from Invitrogen. The p21 WAF1/Cip1 siRNA (s415) was purchased from Ambion (Carlsbad, CA). One day before transfection, HaCaT cells were seeded at 9x10 4 cells/well in 6-well plates without antibiotics. The p15 INK4b , p21
WAF1/Cip1 or a negative control siRNA (20 nM) was transfected into cells using Lipofectamine RNAiMax (Invitrogen) according to the manufacturer's instructions. Twenty-four hours after the transfection, cells were treated with 1.0 mM POH for 24 h and then harvested.
Statistical analysis. Statistical evaluation of the data was performed using the Student's t-test for simple comparison between treatments and controls. p<0.05 was considered to indicate a statistically significant difference.
Results

Cell growth inhibition and G1 arrest by POH in HaCaT cells.
We first investigated the antiproliferative effects of POH in human immortalized keratinocyte HaCaT cells. The growth of HaCaT cells was measured in the presence or absence of various concentrations of POH (Fig. 1A) . POH inhibited the growth of HaCaT cells in a dose-dependent manner. Notably, 1.0 mM POH had a cytostatic effect. To examine the effects of POH on cell cycle progression, the DNA content of cell nuclei was measured by flow cytometry. POH increased the percentage of cells in the G1 phase and decreased the percentage of cells in the S phase in a dose-dependent manner (Fig. 1B ). These data demonstrate that POH arrests the HaCaT cell cycle at the G1 phase.
p15
INK4b and p21 WAF1/Cip1 induction and hypophosphorylation of the RB protein by POH in HaCaT cells. We aimed to elucidate whether cell cycle-associated molecules are influenced by treatment with POH in HaCaT cells. We discovered that POH increased p15
INK4b protein expression in a dose-dependent manner (Fig. 2) . Additionally, POH increased p21
, which is consistent with previous studies (15, 16) . Of note, POH had no effect on the protein expression levels of p27 Kip1 . Both p15
INK4b and p21 WAF1/Cip1 are members of the CKI families and subsequently dephosphorylate the RB protein leading to G1 cell cycle arrest. We, therefore, examined whether POH alters the phosphorylation status of RB. A hyperphosphorylated form of the RB protein was converted into a hypophosphorylated form by POH treatment in a dose-dependent manner (Fig. 2) . Taken together, these results indicate that POH elevates p15
INK4b and p21 WAF1/Cip1 protein levels, and subsequently converts a hyperphosphorylated form of the RB protein into a hypophosphorylated form in HaCaT cells.
Mechanisms of p15 INK4b and p21 WAF1/Cip1 induction by POH in HaCaT cells. We next investigated whether POH affects p15
INK4b and p21 WAF1/Cip1 mRNA expression in HaCaT cells using real-time RT-PCR. Both mRNAs were significantly increased by POH in a dose-dependent manner (Fig. 3A) . Since these mRNAs are induced by POH, we analyzed the effect of POH on the promoter activity using p15
INK4b or p21 WAF1/ Cip1 promoter-luciferase fusion plasmids in a transient assay. POH upregulated the promoter activity of p15 INK4b (Fig.3 B) INK4b -luciferase fusion plasmid (p15) were treated with or without POH at the indicated concentrations for 12 h, and luciferase activity was then measured. Data represent means of triplicate experiments ± SD; * p<0.05, significantly different compared with DMSO-treated control. Figure 2 . Effects of POH on the expression of cell cycle-related molecules in HaCaT cells. HaCaT cells were exposed for 24 h to either DMSO (0 mM) or to POH at various concentrations as indicated. The expression levels of CKIs, p15
INK4b (p15), p21 WAF1/Cip1 (p21) and p27 Kip1 (p27), and RB were analyzed using western blotting. Hyperphosphorylated (ppRB) and hypophosphorylated (pRB) forms of RB are indicated. α-tubulin was used as the loading control.
the induction of these proteins by POH (Fig. 4A) . Additionally, these siRNAs significantly restored POH-altered percentages of the G1 and S cell populations when compared with the control siRNA (Fig. 4B) . These results imply that both p15 INK4b and p21
WAF1/Cip1 play pivotal roles in POH-induced G1 arrest.
POH causes G1 arrest through induction of p15
INK4b and p21 WAF1/Cip1 in other cancer cell lines. To investigate whether the effects of POH on G1 arrest could be observed more generally, other cancer cell lines, HT-29 and SW620, were similarly assayed. POH inhibited the proliferation and caused G1 arrest (p21), RB and α-tubulin (a loading control) proteins was assessed using western blotting. Hyperphosphorylated (ppRB) and hypophosphorylated (pRB) forms of RB are indicated.
in these cells (Fig. 5A and B) . Moreover, POH increased p15
INK4b and p21 WAF1/Cip1 protein expression and hypophosphorylated the RB protein in both cell lines (Fig. 5C ). Taken together, these results suggest that POH has antitumor activity against various malignant tumor cells through induction of p15 INK4b and p21 WAF1/Cip1 and subsequent G1 arrest.
Discussion
Numerous studies have shown that dysfunction of the RB pathway is the most frequent event in human malignant tumors (6, 7) . Therefore, we focused our studies on agents that reactivate RB function through induction of the two CKI families. As a result, we previously demonstrated that p15
INK4b is upregulated by a histone deacetylase inhibitor trichostatin A, a naturally occurring compound indole-3-carbinol, an epidermal growth factor receptor inhibitor gefitinib (ZD1839) and a novel MEK inhibitor JTP-70902 (22) (23) (24) (25) . Additionally, we found that p21 WAF1/Cip1 is increased by trichostatin A, a dietary flavonoid apigenin and a plant alkaloid cryptolepine (26) (27) (28) .
p16 INK4a and p15 INK4b are encoded within the INK4a/ARF/ INK4b locus on chromosome 9p21. Deletion of this locus is the most frequent cytogenetic abnormality of the RB pathway in human hematopoietic malignancies (6) . On the other hand, in many malignant solid tumors, p16
INK4a is inactivated through not only gene deletions, but also point mutations or transcriptional silencing by methylation of the promoter. In contrast to p16 INK4a , however, alteration of the p15 INK4b gene is a rare event in solid tumors (6, 29) . Moreover, among the INK4 family, p15
INK4b has a function similar to that of p16 INK4a . These studies suggest that p15
INK4b may act as a replacement for p16
